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Summary: The following analytes were determined with the automated enzyme immunoassay unit, Enzymun-
Test System ES 300, and by routine in-house tests, and the results were compared: thyrotropin, free thyroxine,
cortisol, immunoglobulin E, digoxin, digitoxin, insulin and carcinoembryonic antigen. The methods used for
comparison included two radioimmunoassays, one with enzyme labelling, two with fluorescence enhanced
enzyme reactions and 3 luminescence immunoassays. In most cases, the precision of the ES 300 lay between
2 and 5% in all assays in the concentration ranges of clinical interest. The inter-assay variation was almost
identical to the intra-assay precision, which reflects the constancy of reagent quality and machine performance.
The correlation between in-house and Enzymun-Test was excellent, even though the slope of the regression
line was sometimes far from unity, due to the calibration materials used.
ES 300 can be used as a stand alone unit and connected to a host computer. As a "walk-away" machine, it
is suitable for laboratories with medium length series. It is a multi-batch analyser capable of taking 12 analytes
and a maximal series length of 136 tubes excluding standards and controls.
Introduction
Enzymun-Test System ES 30Ö is a fully automated
enzyme immunoassay analysis system consisting of a
pipettpr, incubator, photometer and electronic data
processing (EDP)-unit. Interfacing to a central or host
computer is possible as is a manual inpmt via a con-
ventional PC-keyboard. Enzymun-Test System
ES 300 is a bench-top analyser, related to Enzymun-
Test System ES 600 from the same manufacturer (1),
and it is a stand-alone unit. Enzymun-Test System
ES 300 is a patient orientated multibatch analyser
designed as a workhorse for middle sized laboratories
and it can incorporate from 1 to 12 analytes and up
to 150 samples in one run.
Materials and Methods
' Table 1 shows the list of analytes tested, together with the
methods used for comparison.
Tab. 1. List of analytes tested together with methods used for
comparison
Analyte Method of Producer of Kit
comparison*)
CEA
Cortisol
Thyrotropin
Free T4
Digoxin
Digitoxin
IgE
Insulin
IEMA
RIA
ILMA
LIA
FEIA
FEIA
ILMA
RIA
Abbott — EIA Monoclonal
Diagnostic Products-Coat-
a-Count
Behringwerke — BeriLux
Ciba-Corning — Magic Lite
Baxter — Stratus
Baxter — Stratus
In-house assay
Medgenix
*) Key: RIA — Radioimmunoassay
LIA — Luminescence Immunoassay
IEMA — Immunoenzymometric Assay
ILMA — Immunoluniinometric Assay
FEIA — Fluorescence Enhanced Enzyme Immu-
noassay
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Tab. 2. Reference - or therapeutic ranges given by the kit producer1 or established in the laboratory2
Analyte Reference/Therapeutic range
Enzymun-Test
System ES 300
CEA
Cortisol
Thy ro tropin
Free T4
Digoxin
Digitoxin
IgE
Insulin
<4.9
(<2.65
μg/la
ug/0b
70 -250 μg/lc
0.25-
8 -
0.5 -
9 -
<JOO
3 -
3.10
20
2.0
30
17
mU/la
ng/la
μg/la
μg/la
kU/ld
mU/la
Method used
for comparison
<2.5
40 -200
0.20- 3.50
8 - 20
0.8
8
<20
20
5
- 2.2
- 25
-100
- 12
• r
Mg/lb
μ§/1°
mU/lb
ng/1"
velfμβ/ι0
kU/lc (negative)
kU/lc (borderline)
mU/lb
a
 CEA values irrespective of smokers/non-smokers
b
 CEA values established on healthy non-smokers
c
 Cortisol values for 7.00 am.
d
 IgE values above 100 kU/1 indicate an allergy
c
 IgE values under 20 kU/I for normal individuals; values between 20-100 kU/1 do not exclude an allergy.
Table 2 shows the reference or therapeutic ranges for the meth-
ods used as declared by the kit producers.
The in-house method for IgE used antibodies from DAKO —
Hamburg, D and Cappel — Turnhout, B. The label used was
9-(4-aminobutyl-N-ethyl) benzo(f)phthalazine -1,4 (2H, 3H)
dione (ABEN) coupled to the DAKO antibody.
The other kits were used according to the manufacturers' in-
structions.
The Baxter-Stratus was a closed system; the Abbott IEMA was
read off on an Abbott Quantum II manual EIA-reader with
microprocessor and printer.
For the radioisotopically labelled kits, counting was performed
in an NE-1600 16-well manual gamma spectrometer (Thorn-
EMI Sighthill, Edinburgh UK).
For the kits with luminescent labels, measurements were per-
formed in a Berthold LB-952 16 T 250 sample chain lumino-
meter with microprocessor and printer (Berthold-EG & G,
Wildbad, D).
The chromogen used in the Enzymun-Test kit was 2,2'azino-di
[3-ethylbenzlhiazoline 6-sulphonic acid], (ABTS).
Non-parametric statistics were used throughout, regression
lines being constructed using the Passing-Bablok main-com-
ponent analysis method (2).
Tab. 3. Lower detection/decision limits for quantitative docu-
mentation in the Enzymun-Test System ES-300 and u>
house methods
Analyte
CEA
Cortisol
Thyrotropin
Digoxin
Digitoxin
IgE
Insulin
Free T4
Enzymun-Test
System ES 300
0.5 Mg/1
2 Wl\
0.07 mU/1
0.3 μβ/1
2 Wl\
1.5 kU/1
3 rnU/1
2 ng/1
In-house
method
1 μκ/1
5 μβ/1
0.005 mU/1
0.2 μ§/1
2 μ*β
10 kU/1
5 mU/1
1.5 ng/i
Values lower than those in the above table were given as <
"Less than".
or
dard (+3 s for immunometric assays, — 3 s for competitive
assays), derived from duplicate results in 10 consecutive assays.
The lower detection limits used in the ES 300 evaluation were
not calculated during evaluation, but were taken from internal
and external evaluation studies. The intra-assay drift was cal-
culated from 25 identical samples placed at 4 tube intervals
during a run.
Concepts and Targets of the Evaluation
Precis ion and accuracy
For all methods, inter- and imru-ussay coefficients of variation
were determined on pool sera. Three human serum pools of
different concentration and two control sera from Boehringer
Mannheim were used for estimation of inter- and intra-assay
CV for ES 300. Accuracy could not be tested, due to the absence
of reference or definitive methods. The comparison between
ES 300 and the in-house assay may be taken as a relative
estimate of the accuracy by using the slope of the regression
line and intercept value.
Lower detection l imit ( tab. 3) and intra-assay drift
The potential lower detection limit of the in-house assays was
determined from the 99% confidence limit from the zero stan-
Clinical relevance of results
In addition to the classification of results obtained from both
methods, sera giving widely divergent results in both methods
were investigated further for icterus, haemolysis and lipaemia,
taking into account the accompanying clinical diagnosis and,
where known, possible drug interferences.
Results and Discussion
Regression analysis — linear regression ao
cording to Passing-Bablok (2)
Carcinoembryonic antigen — CEA (fig. 1)
Patient samples (n = 140) were measured simulta-
neously with both tests. Twenty runs were performed,
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Fig. 1. Correlation between the Abbott immunoenzymometric
assay (χ) and ES 300 (y) for CEA. Only values under
30 μg/l (n = 131) were used. The line of identity is given
as the dotted line, the regression line y = 0.48 + 0.83x
as the solid line, the correlation coefficient r being 0.98
and the degree of dispersion (τ) 0.74. (This format is
used in figures 1 —4).
in which CEA was one analyte, up to 4 analytes being
measured in one run. Each run included intra- and
inter-assay quality assessment samples.
One sample pair showed repeated aberrant results
(n = 5) with a mean concentration of 7.2 μg/l as
measured on the ES 300 and 1.8 μg/l in the Abbott
immunoenzymometric assay. The sample came from
a patient operated for colon carcinoma.
Nine samples were assayed as < 1 μg/l by the Abbott
Quantum and had values less than 1 μg/l with Enzy-
mun-Test CEA. These were not included in the re-
gression analysis.
Twenty-seven values with an Enzymun-Test System
ES 300 concentration > 1 μg/l and an Abbott IEMA
concentration < 1 μg/l were included in the regression
analysis.
The correlation coefficient of r = 0.977 and τ = 0.74
was excellent, the regression line y = a + bx giving
values for a = 0.48 and b == 0.83.
The values in the range < 25 μg/l (n = 102) were not
significantly different with r = 0.945 and τ = 0.71,
a = 0.66 and b = 0.79.
In the range < 15 μg/l (n = 96), the values were
identical to those quoted above for < 25 μ§/1.
Cortisol (fig. 2)
Ninety-six samples were measured in 20 runs (see
above). Five samples were discarded due to values
lying outside the standard curve.
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Fig. 2. Correlation between the Diagnostic Products Corpo-
ration (DPC) radioimraunoassay (x) and ES 300 (y) for
cortisol using 91 data pairs, y = 13.2 + 0.85x, r = 0.96,
τ = 0.89
Taking all values up to 450
values were as follows:
the regression analysis
Correlation coefficient r = 0.96 and τ = 0.89. Slope
of the regression line b = 0.85, intercept a = 13.19.
Again the correlation was excellent.
Thyrotropin (fig. 3 — values < 3.5 mU/1)
One hundred and fifty-two sera with values under 10
mU/1 were measured in 20 assays; 6 data pairs giving
results under the detection limit (Enzymun-Test Sys-
tem ES 300 < 0.07 mU/1, Behring < 0.005 mU/1)
were excluded from the statistical analysis.
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Fig. 3. Correlation between the Behring Berilux immunolumi-
nometric assay (x) and ES-300 (y) for thyrotropin. Only
values in the hyper- and eulhyroid range (n = 146) are
shown, as this is the region of interest, y = —0.03
+ l.tOx, r = 0.94, τ = 0.85
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The regression line data for the values up to 10 mU/1
were: correlation coefficient r = 0.964, τ = 0.85, in-
tercept 0.03 mU/1, slope 1.10.
For the 139 values under 3.5 mU/1 (i.e. in the euthy-
roid and hyperthyroid range) the corresponding val-
ues were: correlation coefficient r = 0.936, τ = 0.85,
intercept 0.03 mU/1, slope 1.10. The outlier could not
be explained (ES 300 - 3.4 mU/1, Berilux 1.0 mU/1)
as both T3 and fT4 concentrations were within the
euthyroid range.
The diagnostic value of both tests was identical, and
inisclassification errors were not observed.
The lower detection limit of 0.07 mU/1 for thyrotropin'
in Enzymun-Test TSH was perfectly adequate for the
differentation between eu- and hyperthyroid patients.
Free thyroxine — fT4 (fig. 4)
One hundred and sixty-one sera were measured. One
serum, which was icteric, gave repeatedly different
values — with an ES 300 mean concentration 27.4
ng/1, and a Ciba Corning value of 16.3 ng/1 (n = 5).
Although the correlation between both methods was
good(r = 0.861, τ = 0.61), the slope of the regression
curve showed that the results from the ES 300 were
around 40% higher than those measured in the Ciba-
Corning LIA, (intercept -0.87, slope 1.40). These
results point to the general problem of standardisation
in assays for free thyroid hormones.
The standards for the fT4 Enzymun-Test were cali-
brated using values obtained from equilibrium dial-
ysis. Enzymun-Test fT4 values fitted the clinical pic-
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Fig. 4. Correlation between the Ciba-Corning Magic-Lite lu-
minescence immunoassay (x) and ES 300 (y) using free
thyroxine values under 40 ng/1 (n = 161). y = -0.87
+ 1.40x, r = 0.86, τ = 0.61
ture when they were seen in context with the corre-
sponding Enzymun-Test TSH thyrotropin concentra-
tions.
• r
Digoxin
One hundred and forty-four sera were assayed in 20
assays. Four sera with concentrations below the de-
tection limit in both assays were not included in the
statistical evaluation. The results were not as good as
those for the other analyte comparisons. It is known
that the Baxter-Stratus mainly measures non-protein
bound digoxin (personal results and 1. c. (3)), but this
alone cannot account for the discrepancies between
ES 300 and Baxter in at least 10 sera, where the values
in the Enzymun-Test System method were all higher.
It was not possible to decide which method gave the
"correct" values, as a third method (Abbott TDx)
agreed with the values from the Baxter-Stratus in 4
cases and with ES 300 in 3 other cases and gave values
between both methods in a further 3 cases. The overall
correlation was good (r == 0.904), even when the dis-
persion was broader (τ = 0.65), but the intercept (0.15
μg/l) and the slope (1.06) show a small but constant
positive bias in favour of ES 300.
Digitoxin
Here 139 sera were measured in 20 assays, 15 data
pairs being eliminated as the concentrations measured
in both assays lay below the detection limit of the
assays. In contrast to digoxin (see above) the corre-
lation between ES 300 and Baxter Stratus was much
better, with only 1 discrepant value where a toxic
concentration was measured in ES 300 (33 μg/l) but
a therapeutic concentration in the Baxter-Stratus (16
μg/l). This patient was undergoing chronic renal di-
alysis.
The overall correlation was good (r = 0.943,
τ = 0.80) with acceptable intercept (0.08 μg/l) and
slope (0.91).
Immunoglobulin E-IgE
From the 133 samples measured, 32 were not included
in the statistical evaluation as they had values which
were undetectable in both assays.
There were several data pairs which varied widely in
both methods, 4 of which differed by more than a
factor of 2 at concentrations >%200 kU/1.
t
The correlation over the whole range was good
(r = 0.914, τ = 0.77). The in-house method giving
values on average 23% lower than the ES 300.
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If only the values below 250 kU/1 (n = 86) are taken
into consideration, the correlations is slightly worse
(r = 0.911), as is the dispersion of the values
(τ = 0.73). The values of ES 300 lay on average 16%
higher than those from the in-house method. The in-
house method was calibrated using an IgE Standard
Serum from Behringwerke (Catalogue No. OTFK/02-
03). The in-house IgE method was known to give
values consistently lower than the median in an ex-
ternal quality assessment scheme (Wellcome Diagnos-
tics).
Insulin
The insulin values from 113 out of 115 measured sera
were used for statistical purposes. The two data pairs
Tab. 4. Enzymun-Test System ES 300 - Precision data
Analyte
Digoxin (μ§/1)
Mean/Median
s
n
CV %
Digitoxin (μ§/1)
Mean/Median
s
u
CV %
IgE (kU/1)
Mean/Median
s
n
CV %
Insulin (mU/1)
Mean/Median
s
n
CV%
CEA (μ§/1)
Mean/Median
s
n
CV %
Cortisol (μ&/\)
Mean/Median
s
n
CV%
Thyrotropin (mU/1)
Mean/Median
s
n
CV %
Free T4 (ng/1)
Median/Median
s
n
CV %
Pool
PNIM
Intra-
1.35
0.03
20
2.2
Inter-
1.31
0.05
10 χ 3
3.8
Lyphochek 2
16.9
0.84
20
5.0
128
3.75
20
2.9
20.6
1.31
20
6.4
4.27
0.12
2 χ
2.8
125
3.2
2 χ
2.5
3.38
0.14
20
4.0
10.2
0.49
20
4.8
17.2
0.79
10 χ 3
4.6
121
4.53
10 χ 3
3.7
21.1
1.56
10 χ 3
7.4
4.26
0.18
20 10 χ 3
4.3
128
4.4
20 10 χ 3
3.5
3.39
0.13
10 χ 3
3.8
10.4
0.73
10 χ 3
7.0
PPIM
Intra-
3.28
0.03
20
3.3
Inter-
3.16
0.10
10 χ 3
3.3
HS 1
Intra-
0.70
0.02
20
2.5
Inter-
0.73
0.05
10 χ 3
7.4
HS2
Intra-
1.85
0.04
20
1.9
Inter-
1.84
0.07
10 χ 3
3.6
HS 3
Intra-
3.30
0.05
20
1.5
Inter-
3.41
0.11
10 χ 3
3.2
Lyphochek 3
41.6
2.33
20
2.4
163
3.43
20
2.1
67.7
3.66
20
5.4
32.7
0.69
2 χ
2.1
284
4.5
2 χ
1.6
7.31
0.22
20
3.0
44.2
0.75
20
1.7
41.2
1.67
10 χ 3
4.0
159
6.88
10 χ 3
4.3
73.9
5.46
10 χ 3
7.4
32.7
1.15
20 10 χ 3
3.5
284
11.9
20 10 χ 3
4.2
7.56
0.37
10 χ 3
4.9
43.5
0.78
10 χ 3
1.8
6.71
0.24
20
3.6
63.5
2.06
20
3.2
22.0
1.09
20
5.0
3.82
0.16
2 χ 20
3.9
39.8
2.6
2 χ 20
6.5
0.53
0.02
20
4.5
4.10
0.35
20
8.5
6.59
0.28
10 χ 3
6.6
61.2
3.20
10 χ 3
5.3
22.0
1.81
10 χ 3
8.3
3.87
0.17
10 χ 3
4.5
41.8
3.5
10 χ 3
8.3
0.51
0.04
10 χ 3
6.9
3.90
0.42
10 χ 3
10.8
17.1
0.48
20
2.8
173
6.31
20
3.7
47.7
1.72
20
3.6
16.7
0.36
2 χ 20
2.1
144
5.0
2 χ 20
3.5
2.30
0.08
20
3.6
14.5
0.36
20
2.5
16.6
0.69
10 χ 3
4.2
187
7.57
10 χ 3
3.7
48.1
3.30
10 χ 3
8.0
16.6
0.45
10 χ 3
2.7
144
10.0
10 χ 3
6.9
2.24
0.09
10 χ 3
4.0
14.1
0.59
10 χ 3
4.2
29.6
0.85
20
2.9
326
9.02
20
2.8
89.3
3.86
20
4.3
47.1
0.77
2 χ 20
1.6
260
4.5
2 χ 20
1.7
15.2
0.64
20
4.2
37.9
0.76
20
2.0
29.4
1.30
10 χ 3
4.7
301
11.54
10 χ 3
3.8
93.0
4.99
10 χ 3
5.4
47.3
1.32
10 χ 3
2.8
264
10.2
10 χ 3
3.9
15.5
0.90
10 χ 3
5.8
37.6
0.71
10 χ 3
1.9
Intra-assay: n = 20: the mean value is shown; n = 2 χ 20: the mean values of both runs are used for calculation.
Inter-assay: η == number of runs with 3 determination per run; the median values of the three determinations are used for the
calculation of the CV.
Eur. J. Clin. Chem. Ciin. Biochem. / Vol. 31,1993 / No. 3
170 Bauernfeind and Wood: Evaluation of the Enzymun-Test System ES 300
excluded were under the assay limit in both assays.
The results clearly show a standardisation problem in
the assays chosen, as the values from the radioim-
munoassay from Medgenix lay on average 43%
higher than those from the ES-300. The resting insulin
values expected in both kits were similar (Enzymun-
Test System ES 300 less than 17 mU/1, Medgenix less
than 12.5 mU/1) so that the difference in results were
not reflected in the reference ranges given by each
manufacturer. In taking all 113 data pairs, the cor-
relation was very good (r = 0.964, τ = 0.72), the in-
tercept being 3.31 mU/1 and the slope only 0.57.
When including only 93 data pairs below 100 mU/1,
the picture did not change significantly. The correla-
tion and dispersion coefficients were worse
(r = 0.909, τ = 0.68) the intercept (3.48 mU/1) and
slope (0.57) remaining the same.
Precision — Intra- and inter-assay variation
(tab. 4 and 5)
The same 5 pool sera were used to establish the intra-
and inter-assay variation of the ES 300 in 7 of the
assays. In the case of digitoxin, two of the pool sera
were changed, as the originals (PPIM, PNIM) did not
contain digitoxin as declared analyte. Only values for
ES 300 have been taken into consideration. Inter- and
intra-assay data for the in-house assays are given for
reference purposes.
Table 4 summarizes the results for the 8 analytes.
PNIM and PPIM were control sera from Boehringer
Mannheim, HS1, HS2 and HS3 were house-internal
pool sera, Lyphochek 2 and 3 were from Bio-Rad.
The sera used for the calculation of the intra-assay
coefficient of variation were analysed at the beginning
and end of the evaluation of the values in the tables
n = 2 χ 20 represent the mean of these results.
Tab. 5. Quality control data for the in-house methods used for
comparison
Analyte
Thyrotropin
Free T4
CEA
Insulin
Digoxin
Digitoxin
IgE
Cortisol
Range*
0.
5
3
10
0.
5
15
10
1- 50 mU/1
- 40 ng/1
- 50 μ§/1
- 200 mE/1
6- 8 μβ/1
- 90 μδ/1
-3000 kU/1
- 400 μg/l
Intra-assay Inter-assay
CV %** CV %***
2.9
3.5
5.2
5.7
4.3
4.2
5.1
4.8
4.8
7.1
8.1
8.2
5.8
5.3
8.0
6.7
The inter-assay variation was calculated for each of
the control sera run at three points in each of 10 runs.
The value shown here is the median of the 3 values
derived, hence η = 10 χ 3. Table 5 summarizes the
intra- and inter-assay variation of the in-house meth-
ods.
The values in the tables show excellent precision
within the series as well as between runs, so that
values can be determined in singlicate on the ES 300.
Even a precision of 11% at a clearly hypothyroid fT4
concentration of 3.9 ng/1 is clinically acceptable, as
the result would not lead to a misclassification error
as far as diagnosis is concerned.
Signal stability over 100 tube runs (fig. 5)
Figure 5 shows the signal drift for thyrotropin and
free thyroxine. The same sample was assayed every 4
tubes and the resulting absorbance plotted on the
ordinate.
The abscissa shows the tube number. Although inter-
sample variations are seen there is no general drift in
either of the two assays. Similar results were seen for
cortisol and CEA (data not shown).
1.2
0.8
;o.6
0.4
0.2
10 20 30 40 50 60
Tube number
70 80 90 100
* Concentration range with mean intra-assay CV under
10%.
** Derived from precision profiles with η > 200 data pairs.
*** Derived from at least 20 assays.
Fig. 5. This figure shows the signal stability over a lOO-tube
run for thyrotropm (Δ) and free thyroxine (D). The
same sample was placed at 4 tube intervals and was
treated as an unknown.
Further points
The results presented here show on the one hand the
excellent precision expected from a fully-automatic
system. On the other hand, they show the variation
in results, usually of a systematic (standardisation)
nature, encountered in all immunoassays, regardless
of analyte or label. ;
Analytes were chosen to represent immunoassays
where "problems" are often encountered, these being
Bur. J. Clin. Chem. Gun. Biochem. / Vol. 31,1993 / No. 3
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due to cross-reactivity of metabolites, (cortisol, di-
goxin, digitoxin) (4—6), binding proteins in plasma
(fT4) (7, 8), lower detection limit (thyrotropin) (9) and
immunoglobulin interference (CEA) (10). IgE and
insulin were included as analytes which are often
measured using radioisotopic labelling.
The precision of the results allows singlicate analysis
to be performed, as is to be expected from a fully
automated analyser. As stated above, the accuracy
cannot be confirmed, because, with the exception of
cortisol (11), no reference methods are available for
the analytes listed above. Until epitope mapping can
be performed and monoclonal antibodies used to de-
fine the epitopes which can then be quantified, no
progress will be made in this direction, not even with
peptide synthesis (12, 13).
The main aim of correlation studies, apart from the
correlation coefficient (r) and dispersion around the
regression line (τ), must be the exclusion of misclas-
sification errors by using the reference ranges set up
for the assays used.
The assays tested on the ES-300 showed a good cor-
relation with the in-house methods within the limi-
tations described, and they fulfilled the laboratory
criteria with regard to precision and classification of
results.
The ES 300, designed as a computer-controlled fully
mechanised system, shows distinct advantages when
integrated into the laboratory routine.
The interactive dialog on the monitor was seen as
positive by laboratory technicians, and the possible
use of code words prevents tampering by persons not
involved in operation of the ES 300. The computer
(EPSON AX-2 with VGA-Monitor (colour) and EP-
SON LQ-550 Printer, 2 χ 5£" 1.2 MB floppy disks
and 40 MB hard disk) is perfectly designed for con-
trolling the ES 300.
In laboratories which have an on-line link to a host
computer, all data can be transferred using a bidirec-
tional interface. As this was not the case in this
evaluation study, all data were entered by hand. De-
spite this fact, the ES 300 was fully accepted by the
laboratory technicians.
Future developments include the introduction of a
bar-code reader which will facilitate communication
at the local level, especially in the entry of patient
identity and test-kit characteristics, as well as a soft-
ware based on Microsoft Windows®. A major advan-
tage of ES 300 was that after pressing the "Run key",
the technician could leave the machine.
The computer program allows for run optimisation
so that in the case of multi-analyte runs, the incuba-
tion/wash steps are so ordered that the total length
of time of the run is minimised. Assays which do not
meet the internal quality criteria (curve-fit) are not
released. The assistant must check all data, and then
decide on the course of further actions to reject the
results or re-run the test.
The use of a one-point recalibration within a single
lot of reagents reduces the costs incurred in manual
or semi-automatic methods. The precision allows
singlicate determinations and the mean time between
service (MTBS) of around 6 months makes the ES
300 an attractive alternative in laboratories perform-
ing series of 20 —50 patient samples at regular inter-
vals. The "big-brother" Enzymun-Test System ES
600/700 is better suited for longer runs.
The documentation of results can be altered to meet
the individual needs of the user so that test reports,
sample lists, patient reports and ward lists are all
possible.
The use of an enzyme label (peroxidase) and stable
chromogen with high molar absorbance (ABTS) (14)
reduce the lower detection limit, as well as the time
of the colour development step. The use of one en-
zyme-substrate system also simplifies the assay design
as far as automation is concerned. Many reagents are
useable in several assays — which cuts down reagent
storage space. This tendency will be continued, espe-
cially with the introduction of a "universal tube" using
the streptavidin-biotin technology. Assays for ana-
lytes such as thyrotropin and oestradiol (data not
shown here) show that low detection limits are at-
tainable.
The total number of analytes available for the ES 300
is over 30 and covers the fields of endocrinology,
tumour markers, viral infections, drug monitoring
and other proteins and haptens, so that the majority
of analytes in a routine immunoassay laboratory are
covered — an important point when considering the
introduction of a computer-assisted analyser.
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Summary: A multi-centre study was undertaken to evaluate the performance of the Reflotron® high density
lipoprotein cholesterol method in twelve different clinical chemistry hospital laboratories.
Results were compared with phosphotungstic acid/Mg2+ and polyethylene glycol/dextran sulphate/Mg 2+
precipitation methods, routinely performed in these laboratories.
Precision was found to be excellent, for both the day-to-day results (SD = 0.03 mmol/1) and for the overall
between-laboratory precision (SD = 0.02 mmol/1), measured with control sera.
HDL cholesterol concentrations measured with the Reflotron® system were about 10% lower than those
obtained with the two routine precipitation methods, using different instruments with different cholesterol
standardization procedures.
Introduction . . ~
 r , , ,Λ _ N _interference from drugs or other sources (1, 3). Every
After the introduction of the Reflotron® assay for reagent strip is magnetically coded with the charge-
high density lipoprotein cholesterol, which uses dry specific calibration,
chemistry reagent and requires no precipitation step
(1), reports were published on the evaluation of this During the last decade several comparison studies
method and its comparison with the phosphotungstic were made between different precipitation methods
acid/Mg*+ precipitation method (2-4). These eval- (5-8). The major source of error in the separation
uations show acceptable linearity (3) and hardly any procedure for HDL in serum is the turbidity of su-
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pernatants. Lippi et al. (9) solved this problem for
hyperlipidaemic samples by using a mixture of poly-
ethylene glycol, dextran sulphate and MgCl2 as the
precipitation reagent. A test kit with the same reagent
concentrations is distributed in the Netherlands and
is used in about 40% of the clinical chemistry labo-
ratories in the North of the Netherlands.
It was our aim to compare the results of measurements
performed with the Reflotron® analyser with the re-
sults obtained with both of the above-mentioned pre-
cipitation methods, which are in routine use in twelve
different hospital laboratories in the northern region
of the Netherlands.
Materials and Methods
The Reflotron^· system (Boehringcr Mannheim GmbH, Mann-
heim, Germany) has been described before and the instruments
were operated according to the manufacturer's instructions.
EDTA-plasma is used, and precipitation and lipoprotein frac-
tionation by means of dextran sulphate and magnesium ions
takes place in the precipitation layer. The precipitation fractions
are filtered by the transport layer and only the HDL fraction
reaches the indicator film, where the HDL cholesterol concen-
tration is determined enzymatically by a cholesterol oxidase/
peroxidase reaction, measured at 642 nm. The Reflotron^ is
calibrated against the phosphotungstate method of Boehringer
Mannheim. · r
Twelve Reflotron® systems were installed in twelve different
clinical chemical hospital laboratories in the northern region of
the Netherlands for a 2-week period (tab. 1). The responsible
technicians were instructed by the same Boehringer Mannheim
employees. One lot of Reflotron® reagent tabs was used.
Seven of these laboratories (lab 1—7) routinely used a phos-
photungstic acid/magnesium ion precipitation method (Boeh-
ringer Mannheim No. 543004). Six then used the cholesterol
CHODrPAP method (Boehringer Mannheim No. 642905) on
the following mechanized analysers: Hitachi 704 (Boehringer
Mannheim), Cobas Fara (Hoffman-La Roche, Basel, Switzer-
land) and Monarch (Instrumentation Laboratory, Lexington,
USA) using different calibration procedures. The other used a
CHOD-PAP method manufactured by Technicon (Bayer AG,
Leverkusen, Germany, No. 6671) on ä RA-1000 (Technicon,
Tarrytown, USA). Five of these laboratories (8-12) routinely
used a polyethyleneglycol 6000/dextran sulphate/magnesium
ion precipitation method (Instruchemie B. V., Hilversum, The
Netherlands, No. 2258). Four of these then used the same
cholesterol method (Boehringer Mannheim) on the following
mechanized analysers: Cobas Mira, Cobas Fara, Monarch and
Hitachi 717 using different calibration procedures. The other
Tab. 1. Characteristic features of the phosphotungstate/Mg2+ and the polyethylene glycol/dextran sulphate/Mg2+ precipitation
methods used in the J2 hospital laboratories for the routine determination of HDL cholesterol in serum.
Hospital Routine method Calibration
1
10
11
12
Phosphotungstic acid/Mg2+ CHOD-PAP (BM)
HITACHI 704, 505 nm, 30 °C
Phosphotungstic acid/Mg2+ CHOD-PAP (BM)
HITACHI 704, 505 nm, 30 °C
Phosphotungstic acid/Mg2+ CHOD-PAP (BM)
COBAS FARA, 500 nm, 37 °C
Phosphotungstic acid/Mg2+ CHOD-PAP (BM)
HITACHI 704, 505 nm, 30 °C
Phosphotungstic acid/Mg2+ CHOD-PAP (BM)
COBAS FARA, 500 nm, 30 °C
Phosphotungstic acid/Mg2+ CHOD-PAP (B)
RA-1000, 500 nm, 30 °C
Phosphotungstic acid/Mg2+ CHOD-PAP (BM)
MONARCH, 500 nm, 30 °C
Polyethylene glycol/dextran sulphate/Mg2+ CHOD-PAP (Ic)
COBAS MIRA, 500 nm, 30 °C
Polyethylene glycol/dextran sulphate/Mg2+ CHOD-PAP (BM)
COBAS MIRA, 500 nm, 30 °C
Polyethylene glycol/dexlran sulphate/Mg2+ CHOD-PAP (BM)
COBAS FARA, 500 nm, 37 °C
Polyethylene glycol/dextran sulphate/Mg2+ CHOD-PAP (BM)
MONARCH, 500 nm, 30 °C
Polyethylene glycol/dextran sulphate/Mg2+ CHOD-lPAP (BM)
HITACHI 717, 505 nm, 30 °C
Multi-calibrator (BM)
Precimat (BM)
Setpoint (B)
Multi-calibrator (BM)
Multi-calibrator (BM)
Precinorni L (BM)
Precinorm L (BM)
Artificial cholesterol standard
HDL-cholesterol standard (Ic)
Factor calculated with reference sera
HDL-cholesterol standard (Ic)
HDL-cholesterol standard (Ic)
B = Bayer
BM = Boehringer Mannheim
Ic = Instruchemie
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used a CHOD-PAP method from Instruchemie (No. 2142) on
a Cobas Mira.
Day-to-day precision of the Reflotron* method was assessed
by analysing two control sera, namely Precinorm® HDL-2 with
an assigned value of 0.75 mmol/1 HDL cholesterol (Boehringer
Mannheim) and QCS Normal Unassayed, a human control
serum manufactured by Ciba-Corning, Irvine, USA, over a
period of 10 days in single mode. Four users of the phospho-
tungstate/Mg2"1" procedure and four users of the polyethylene
glycol/dextran sulphate/Mg2"1" procedure analysed the same
control sera with their routine methods over a period of 4—10
days in single mode.
Two different control sera from one lot, namely Precinorm® L
with an assigned value of 1.06 mmol/1 HDL cholesterol and
Precinorm® HDL-1 with an assigned value of 1.09 mmol/1 HDL
cholesterol, were both distributed to all the laboratories in two
bottles with the indications A/C and B/D, respectively. Bottles
A and B were analysed in single mode in the first week and
bottles C and D were analysed in the second week both on the
Reflotron® and with the routine method.
Comparison studies were made by analysing more than 500
fresh patient samples with the Reflotron'* and the routine
methods in single mode over the period of 2 weeks at the 12
locations. The HDL-cholesterol concentrations covered a con-
centration range of 0.34 to 2.23 mmol/1.
Results and Discussion
Precision and accuracy
The results for day-to-day precision using the two
control sera based on human serum (Precinorm®
HDL-2 and QCS Nor Unasy) are shown in table 2.
The mean within-laboratory coefficients of variation
measured at the 12 locations for the two control sera
were 4.0% (range 2.3-6.1%) and 2.8% (range 1.5-
3.5%), respectively. These results are better than those
published by Leinberger (1), and the overall mean
standard deviation for both these sera (0.03 mmol/1,
range 0.01 —0.05 mmol/1) is better than the allowable
limits proposed by the CDC-NHLBI Lipid Standard-
ization Programme, i.e. 0.08 mmol/1 (10).
These results are also better than the mean results
measured with the routine methods after phospho-
tungstate/Mg2+ and polyethylene glycol/dextran sul-
phate/Mg2"1" precipitation, which showed coefficients
of variation of 4.4% and 4.3%, respectively. Although
Tab. 2. Day-to-day precision results of HDL cholesterol measured in two control sera with the Reflotron'* system in the 12
hospital laboratories. Most laboratories also measured the concentrations with their routinely performed precipitation
method.
Hos- Method*
pital
1 Reflotron
2 Reflotron
Phosphotungstate
3 Reflotron
Phosphotungstate
4 Reflotron
5 Reflotron
Phosphotungstate
6 Reflotron
Phosphotungstate
7 Reflotron
χ Reflotron
χ Phosphotungstate
8 Reflotron
Polyethylene glycol
9 Reflotron
10 Reflotron
Polyethylene glycol
1 1 Reflotron
Polyethylene glycol
12 Reflotfon
Polyethylene glycol
χ Reflotron
χ Polyethylene glycol
Overall χ Reflotron
η Precinorm HDL-2
(assigned value = 0.75 mmol/1)
9
10
4
10
10
10
10
4
10
10
10
69
28
10
9
10
10
10
10
6
10
10
50
35
χ (mmol/1)
0.76
0.75
0.87
0.78
0.85
0.74
0.77
0.84
0.75
0.84
0.77
0.76
0.85
0.76
0.78
0.78
0.79
0.82
0.76
0.87
0.72
0.85
0.76
0.83
0.76
SD (mmol/1)
0.04
0.03
0.07
0.02
0.05
0.03
0.02
0.02
0.04
0.03
0.05
0.03
0.04
0.03
0.01
0.03
0.02
0.05
0.02
0.05
0.03
0.03
0.03
0.04
0.02
CV (%)
4.7
4.2
8.4
2.3
5.7
3.9
3.3
2.0
5.5
3.8
6.1
4.3
5.0
4.6
0.9
3.3
3.2
6.3
2.3
5.9
4.0
3.1
3.5
4.0
2.5
QCS Normal
(mmol/1)
χ (mmol/1)
1.00
0.97
1.04
0.98
1.07
0.97
0.94
1.02
1.00
1.06
—
0.98
1.05
0.97
1.03
0.99
—
0.97
1.11
0.92
1.06
0.96
1.07
0.97
Unassayed
SD (mmol/J)
0.03
0.01
0.07
0.03
0.05
0.03
0.03
0.01
0.03
0.03
—
0.03
0.04
0.02
0.02
0.03
—
0.02
0.08
0.03
0.05
0.02
0.05
0.03
CV (%)
3.4
1.5
6.5
2.6
4.8
3.5
3.0
1.4
3.5
2.7
—
2.9
3.8
2.3
2.4
2.7
—
2.2
7.1
3.4 -
4.4
2.6
4.6
2.6
* Phosphotungstate = phosphotungstic acid/Mg2"1*
Polyethylene glycol = polyethylene glycol/dextran sulphate/Mg2*
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not all the laboratories participated in the routinely
performed measurements, and the data for the control
sera were obtained over 4-10 days, the results were
comparable with the mean coefficient of variation
found for the comparison phosphotungstate/Mg2+
method in the Boehringer study, namely 4.4% (1).
The mean results of the phosphotungstate/Mg2+ and
polyethylene glycol/dextran sulphate/Mg2"1" methods
for both control sera were 0.08 mmol/1 (range 0.07-
0.11 mmol/1) higher than the Reflotron® results, which
is significant for both methods and both sera
(p > 0.05).
The mean HDL cholesterol concentration of the Pre-
cinorm® HDL-2 measured with the Reflotron® in the
12 laboratories was remarkably close to the Boehrin-
ger Mannheim assigned HDL cholesterol value (0.76
mmol/1 vs. 0.75 mmol/1), and the overall between-
laboratory precision for both control sera was very
small, namely 2.5% and 2.6%.
The results obtained with the unknown control sera
A-D (Precinorm® L and Precinorm® HDL-1, with
Boehringer Mannheim assigned HDL-cholesterol val-
ues of 1.06 mmol/1 and 1.09 mmol/1, respectively),
measured once in both weeks with the Reflotron® and
with the phosphotungstate/Mg2+ and polyethylene
glycol/dextran sulphate/Mg2+ precipitation methods,
can be summarized as follows. The HDL cholesterol
overall mean of Precinorm® HDL-1 was almost iden-
tical with the Boehringer Mannheim assigned value,
namely 1.10 mmol/1 vs. 1.09 mmol/1, and was meas-
ured with good between-laboratory precision in the
12 laboratories (coefficient of variation = 3.6%). Al-
though the Precinorm® L control serum was not de-
veloped for use on the Reflotron® system, and the
Reflotron® HDL cholesterol value was therefore far
below the Boehringer Mannheim assigned value, this
control serum was measured with the same SD = 0.04
mmol/1.
The phosphotungstate/Mg2+ precipitation method,
which was used in 7 laboratories, gave a mean HDL
cholesterol concentration for the Precinorm® L close
to the Boehringer Mannheim assigned value, namely
1.10 mmol/1 vs. 1.06 mmol/1, and the precision was
excellent (coefficient of variation = 2.1 %). These lab-
oratories reported a slightly higher HDL cholesterol
concentration for the Precinorm® HDL-1, namely
1.27 mmol/1 vs. 1.09 mmol/1, with almost the same
excellent precision (coefficient of variation = 1.8%).
The mean HDL cholesterol results obtained with the
polyethylene glycol/dextran sulphate/Mg2+ precipi-
tation method were almost the same (1.08 mmol/1 and
1.25 mmol/1), but the precision was less, with a co-
efficient of variation of 6.0% and a coefficient of
variation of 4.3%.
Method comparison
Table 3 shows the comparison of results from the 12
laboratories for the determination of HDL cholesterol
by the analysis of EDTA-plasma on the Reflotron®
and by the analysis of serum samples by phospho-
tungstate/Mg2+ and polyethylene glycol/dextran sul-
phate/Mg2+ precipitation methods. Two hundred and
ninety six samples were measured at 7 locations with
Tab. 3. Comparison of results from 12 hospital laboratories for the determination of HDL cholesterol by the analysis of EDTA-
plasma samples on the Reflotron® system and by the analysis of serum samples by phosphotungstate/Mg2"*" and
polyethylene glycol/dextran sulphate/Mg2"1" precipitation methods.
Hos-
pital
1
2
3
4
5
6
7
Overall
8
9
10
11
12
Overall
Method*
Phosphotungstate
Phosphotungstate
Phosphotungstate
Phosphotungstate
Phosphotungstate
Phosphotungstate
Phosphotungstate
χ phosphotungstate
Polyethylene glycol
Polyethylene glycol
Polyethylene glycol
Polyethylene glycol
Polyethylene glycol
χ polyethylene glycol
n
35
45
52
24
52
51
37
296
48
47
48
39
43
225
Range Reflotron
(mmol/1)
0.54-1,66
0.53-2.05
0.63-2.23
0.65-1.85
0.48-1.68
0.60-2.22
0.59-2.12
0.48-2.23
0.71-1.70
0.34-1.86
0.66-2.09
0.59-2.14
0.45-1.46 '
0.34-2.14
Slope
1.23
1.12
1.16
1.17
1.17
1.05
1.10
1.14
1.26
0.98
1.02
1.02
0.98
1.05
Intercept
-0.08
0.00
-0.14
-0.06
-0.06
0.02
-0.01
-0.05
-0.19
0.18
-0.03
0.01
0.10
0.01
r
0.932
0.930
0.939
0.968
0.969
0.982
0.965
0.955
0.970
0.963
0.967
0.948
0.965
> 0.963
syx
0.069
0.091
0.106
0.064
0.060
0.045
0.065
0.071
0.060
0.054
0.068
0.085
0.048
0.063
* Phosphotungstate = phosphotungstic acid/Mg2*
Polyethylene glycol = polyethylene glycol/dextran sulphate/Mg2+
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the Reflotron® system and by phosphotungstate/
Mg2+ precipitation, while 225 samples were measured
at 5 locations with the Reflotron® system and by
polyethylene glycol/dextran sulphate/Mg2+ precipi-
tation.
Regression analysis was done according to the Passing
& Bablok (11) procedure to determine slope and in-
tercept of the regression line. The Reflotron® vs phos-
photungstate/Mg2+ regression analysis give a mean
slope of 1.14 (range 1.05—1.23) with a small mean
intercept of -0.05 mmol/1 (range -0.14 - +0.02
mmol/1) compared with the Reflotron® vs polyethyl-
ene glycol/dextran sulphate/Mg2+ results of 1.05
(range 0.98-1.26) and 0.01 mmol/1 (range -0.19 -
+ 0.18 mmol/1). These differences are not significant
(p > 0.05).
It is notable that the laboratory in the group of
polyethylene glycol/dextran sulphate/Mg2 + users that
applies an artificial cholesterol standard solution for
calibration, also reports rather high HDL cholesterol
concentrations (above 1.5 mmol/1) compared with the
Reflotron® method.
Removing thirteen data points > 1.5 mmol/1, the new
regression equation has a slope of 1.16 and an inter-
cept of — 0.09, which results in a total mean slope of
| the polyethylene glycol/dextran sulphate/Mg24" group
' of 1.03 and a mean intercept of 0.03.
t
The mean slope of the Reflotron® vs phosphotungs-
tate/Mg24" comparison results in this study is signifi-
cantly higher than the mean slope found in the Boeh-
ringer Mannheim comparison (1) of the Reflotron®
and phosphotungstate/Mg2H~ method (also performed
with 7 laboratories, and with a total of 683 samples),
( where a mean slope of 1.01 was found. Mean intercept
j (—0.02 mmol/1) and mean correlation coefficient
I (0.955) were almost identical.
; In other studies, where the Reflotron® HDL choles-
i terol method (x) was evaluated against Boehringer
\ Mannheim phosphotungstate (y) for EDTA-anticoa-
; gulated specimens, somewhat intermediate slopes and
| comparable intercepts and correlation coefficients
| were found:
j n Slope Intercept r Reference
100
136
137
1.05
1.02
1.08
-0.03
-0.01
-0.12
0.977
0.978
0.954
2
3
4
j To make an overall comparison between both precip-
itation methods and the Reflotron® method, we
pooled the data of 5 laboratories using the phospho-
tungstate/Mg2* procedure (3—7) with η = 216 and
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range 0.48—2.23 mmol/1, and 5 laboratories using the
polyethylene glycol/dextran sulphate/Mg2+ procedure
(8-12) with n = 225 and range 0.34-2.14 mmol/1.
The regression line for the Reflotron® (x) vs phos-
photungstate/Mg2+ (y) comparison is found to be
y = 1.12 x - 0.03 (r = 0.959 and sy.x = 0.074), and
almost the same for the Reflotron® vs polyethylene
A
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Fig. 1. Comparison of HDL cholesterol concentrations deter-
mined with the Reflotron® system (abscissa) and the
phosphotungstic acid/Mg2* precipitation method (or-
dinate) in 216 fresh EDTA-plasma and serum samples,
respectively, in 5 hospital laboratories. Regression equa-
tion: y = 1.12 x - 0.03.
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Fig. 2. Comparison of HDL cholesterol concentrations deter-
mined with the Reflotron® system (abscissa) and the
polyethylene giycol/dextran sulphate/Mg2"*" precipita-
tion method (ordinate) in 225 fresh EDTA-plasma and
serum samples, respectively, in 5 hospital laboratories.
Regression equation: y = 1.09 x — 0.02
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glycol/dextran suiphate/Mg2+ comparison, namely
y = 1.09 - 0.03 (r = 0.949 and sy.x = 0.075). These
results, also shown in figures 1 and 2, give rise to the
conclusion that there is a significant difference be-
tween the precipitation methods on the one hand and
the Reflotron® method on the other hand, especially
for higher HDL cholesterol concentrations.
Conclusions
From this study, performed in 12 hospital laborato-
ries, it is clear that the HDL cholesterol determination
performed on the Reflotron® system with EDTA-
plasma samples is a precise and reliable procedure.
Overall between-laboratory precision was found to be
rather low, compared with the phosphotungstate/
Mg2* and polyethylene glycol/dextran sulphate/Mg2+
precipitation methods, routinely performed in these
laboratories.
Method comparison showed that HDL cholesterol
concentrations determined on Reflotron® were about
10% lower than those reported by the two routine
precipitation methods, while these two latter methods
gave almost identical regression lines compared with
the Reflotron® results. This difference is somewhat
higher than found in other comparison studies (1 —4).
As the routine precipitation methods are somewhat
different with respect to instrumentation and choles-
terol standardization, and this group of laboratories
performs well in external schemes (typical between-
laboratory standard deviation = 0.04 mmol/1), the
overall mean must lie rather cloSe to the "true" HDL
cholesterol value for these precipitation methods. This
measured difference leads us to question the calibra-
tion of the Reflotron® instrument, a subject also dis-
cussed in earlier Reflotron® studies (12—13).
Despite these positive results and the fact that the
precipitation step has to be performed manually be-
fore the sample can be analysed on an automated
instrument, the opinion of the participating labora-
tories is that this Reflotron® method is too time-
consuming (90 s per test) and too expensive for im-
plementation in a well equipped clinical hospital lab-
oratory.
This conclusion holds for determinations performed
in series, but may be quite different when a rather
low sample through-put is analysed, or when a Reflo-
tron® is developed on which more tests can be per-
formed simultaneously.
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Evaluation and Performance of the Coulter STKS
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Summary: The Coulter STKS is a fully automated haematology analyser which quantitively measures and
computes haematological quantities including a full "five-part" differential. The aim of this study was to
evaluate whether the Coulter STKS can be used for screening purposes in a non-academic clinic. Results from
the haemocytometry part of the apparatus correlated very well with those from the Coulter S Plus IV.
Reasonable to good correlations were obtained with the standard manual 100-cell differential for neutrophils,
lymphocytes, monocytes and eosinophils. Significantly higher percentages of monocytes were found by
microscopic observation than by the STKS. Samples from 1080 patients were analysed on the STKS, and
manual differentials were also performed. After revision of discrepancies and with the exclusion of neonatal
samples, a good numerical agreement for the "five-part" differential was obtained. The STKS gave 1.8% false
negatives, and both diagnostic sensitivity (96.3%) and specificity (83.3%) were high. A false negative rate of
1.9% was found for the indication leftshift, with a predictive value of a negative test of 97.4%. The predictive
value of a positive test, however, was only 40.3%.
An authorization procedure was implemented to reduce false negative samples. The routine laboratory work
load for our differentials can be reduced by up to 70%. The Coulter STKS gave a high number of suspect
flags for neonatal samples (75%) and is therefore not suitable for screening neonates.
from the Coulter S Plus IV (haemocytometry) and
The field of haemocytometry and leukocyte differ- with the manual differential. Because of practical con-
entitation has changed dramatically in recent years. siderations we chose to compare the STKS differential
_ . . , ι · j j ι_· -L · t_i with ^e 100 cell microscopic differential. When dis-Recently equipment has been introduced which is able . . , . . ,
r e ^ j-rr *- i u r τ. crepancies arose, a comparison was made with theto perform a five-part differential by means of phys-
 A* „ . . ,._ . , A ,. .
. ι „
 /0 XTC ΟΛΛΛ r* u c-r^o 4QQ cell microscopic differential. A preliminary reportical measurements (Sysmex NE 8000, Coulter STKS - , ... , v_ . , ,^Λ u ^ iirN ΟΛΛΛ^ΟΛ TM. /- u οττ^c "as been published elsewhere (2).and the CellDyn 3000CS). The Coulter STKS was ^ v '
introduced in 1989 and combines the Coulter STKR We also investigated whether the expectations raised
(haemocytometry and three-part differential) with the by the evaluation were fulfilled under practical con-
Coulter VCS (five-part differential). In the VCS part, ditions.
cells are measured by impedance (V, volume), con-
ductivity (C) and ligth scatter (S). The computer plots
the data two- and pseudo-three-dimensionally. Eval- Materials and Methods
uations of the Coulter VCS showed that the apparatus instrumentation
could be used as a sieve for differentials (1).
The Coulter STKS is a discrete haematology analyser which
This article describes the evaluation of the Coulter uses 25° \& EDTA whole blood in the automatic mode, and
crrtro · 4-u ο* Α>ΓΛΛ..+Α~Λ ττΛ«~;+Λι „+ \7~„i~ τ>Α« ι*« 150 μ! EDTA whole blood in the manual mode. In the automaticSTKS in the St. Maartens Hospital at Venlo. Results
 raode the apparatus uses up to 12 stackable cassettes with 12
from the Coulter STKS were compared with those sample positions each.
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A small part of all the whole blood (35 μΐ) goes to the flow-
cell, and after lysis of the red cells the white cells are subdivided
into 5 populations by 3 different measurements (VCS). The
STKS measures about 8000 cells in less than 20 s. The remaining
part of the blood is divided between an erythrocyte/thrombo-
cyte and a leukocyte channel. The number of cells is counted
by the aperture impedance method. Haemoglobin is measured
in a spectrophotometer. The Coulter STKS has a barcode reader
to identify samples and it can be linked to a host computer.
The capacity of the apparatus for a complete blood determi-
nation is 100 samples per hour.
Sampling
Blood was collected by venipuncture in 2.7 ml Safety-Monov-
ette EDTA tubes (Sarstedt, K2EDTA, 1.5 g/1 blood). For neo-
nates we used Microtainers with EDTA (Becton Dickinson).
When a differential was requested, a wedge film was made
immediately after blood collection, and stained with May-Gmn-
wald-Giemsa stain in an automated staining machine (Varistain
12, Shandon Elliot).
Eva lua t ion protocol
As far as possible the protocol of the International Committee
for Standardization in Haemotology (ICSH) and the U. S. Na-
tional Committee for Clinical Laboratory Standards (NCCLS)
was followed (3, 4). However, because of limited staff numbers,
we chose to perform a 100 white blood cell manual differential,
and when discrepancies arose between the manual and STKS
differential, the manual white blood cell differential was revised
by counting 400 cells.
During the evaluation, and later in the daily routine, the soft-
ware version ID was used.
Manual d i f ferent ia l
A 100 cell differential was performed as a standard by experi-
enced technologists, who did not have any knowledge of the
results of the Coulter S Plus IV or the Coulter STKS. Before
the evaluation, criteria were set, according to which a quanti-
tative score was assigned to the respective abnormalities of the
manual differential (for details see 1. c. (2)). For the abnormal-
ities in the red and white cells a score of 0, 1 or 2 was generally
given to the indications 1+, 2+ and 3 + . The total score of
the manual differential was added and considered as positive
if it equalled or exceeded 2. The presence of blasts was always
a positive score.
For the indication of leftshift, the following norm was used:
Type of cell Fraction
Band
Metamyelocyte
Myelocyte
Promyelocyte
Spo-
radic
—1
2
1-
5%
1
2
3
6-
10%
1
2
3
11-
15%
2
3
16-
20%
3
>20%
4
In addition, the score of toxic granulation and Dohle (l -f =0,
2+ and 3 + = 1) was added. Leftshift was considered as positive
if the score equalled or exceeded 2.
Calibrat ion Coulter STKS
Before the evaluation, the Coulter STKS was calibrated ac-
cording to the instruction of the company. We did not detect
any drift in the equipment.
Reference values
Blood samples from 206 donors and healthy hospital volunteers
in the age range 18—65 years were analysed on the Coulter S
Plus IV and the Coulter STKS to calculate the reference values.
At the same time a manual differential was performed. Table 1
shows the reference values for the differentials.
Tab. 1. Reference values (95% interval) for differentials
Neutrophils ({
Lymphocytes ((
Monocytes ((
Eosinophils (c
Basophils ((
N
/ο) 191
/ο) 191
/ο) 191
/ο) 194
/ο) 192
Manual
differentiation
37.5-73.9
17.2-50.8
0.7-13.1
0 - 6.5
0 - 1.9
Coulter
STKS
38.7-72.7
21.5-48.3
2.6- 8.2
0 - 8.2
0 - 2.5
Patient population
During a period of 5 weeks all patient samples with a differential
request were analysed. Our goal was to compare at least 1000
patient samples.
Statistical interpretation of results
Patient data were stored in a HP 9000 Unix computer with the
ORACLE relational database management system and calcu-
lations were performed with the statistical packets SPSS and
Statgraphics.
A 95% reliability interval for the number of counted cells (100
or 400) was assigned to every quantity in the manual differ-
ential, according to Rurnke (5). When the STKS percentage was
within this 95% interval the data were considered to be con-
cordant. Orthogonal regression analysis was used for correla-
tion comparisons (6).
Results
Analytical aspects, haemocytometry
The analytical aspects were treated in detail in an
earlier report (2), in which we showed that samples
for differential analysis can be stored up to 8 hours.
After 24 hours several suspect flags appeared and
division of cell clusters was no longer possible. The
between-batch-precision was good. Carry-over was
negligible. Linearity was determined with the auto-
mated and manual mode. We could not detect any
difference between these two modes. A good linearity
was found for haemocytometrical quantities. The hae-
mocytometry data of the Coulter STKS correlated
very well with those of the Coulter S plus IV, except
for the red cell distribution width, for which the STKS
gave slightly higher values.
Comparison of manual differential with
Coulter STKS differential·?
Table 2 shows the correlation between the percentages
of the "five-part" 100-cell manual differential and the
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Tab. 2. Correlation of the "five-part" differential microscopic analysis of 100 cells with the results from the Coulter STKS
Neutrophils
Lymphocytes
Monocytes
Eosinophils
Basophils
N
197
200
201
198
191
Regression analysis
y =
y =
y =
v ==
y =
1.040
1.003
0.667
0.738
-0.079
X
X
X
X
X
- 2.450
- 0.135
-h 1.099
+ 0.922
+ 0.768
r
0
0
0
0
-0
Reliability
interval for
mean difference
.917
.915
.550
.804
.031
(D)
-2.72
-2.67
-2.75
-0.04
-h 0.25
<
<
<
<
<
D <
D <
D <
D <
D <
+ 2.92
+ 2.75
+ 2.67
+ 0.86
+ 0.56
Random selection from total patient population (with the exception of neonatal samples)
χ = microscope differential (100 cell count)
y = Coulter STKS differential
r = correlation coefficient
Tab. 3. Appearance of suspect flags on the Coulter STKS
Suspect flag
1. Blast
2. Immature granulocytes/bands
3. Variant lymphocytes
4. Review slide
5. Nucleated red blood cells
6. Dimorphous red blood cell population
7. Micro red blood cell fragments
8. Red blood cell agglutination
9. Platelet clumps
10. Giant platelets
Number of patients
Patients involved in evaluation
Population
without neonates
29
139
16
31
16
7
6
0
2
2
1016
985*
Neonates
11
22
15
11
12
4
5
0
3
2
64
53*
Total
population
40
161
31
42
28
11
11
0
5
4
1080
1038*
Number of patients with the exclusion of neonates: 1016, of which 201 (19.8%) with suspect flag;
number of neonates: 64, of which 48 (75%) with suspect flag;
total patient population: 1080, of which 249 (23.1%) with suspect flag
* Number of patients (in the respective column) minus suspect flag no. 4 (review slide) in the respective column.
Coulter STKS for a random selection of 200 patient
samples. Good correlations were obtained for the
neutrophils, lymphocytes and eosinophils. Signifi-
cantly lower percentages were found on the Coulter
STKS for the monocytes. This can be attributed to
the unequal distribution of monocytes in the film
wedges. The correlation of the basophils was ex-
tremely poor, and this may be due to the low number
of basophils in the film wedge (reference value to
1.9%).
Table 3 shows the suspect flags which appear in the
total population of 1080 patients (several suspect flags
are possible per sample). The group of 64 neonatal
samples give far more suspect flags (75% of the ne-
onatal samples) than the group of remaining patient
samples (almost 20%). Whenever the STKS is used
as a differential sieve, the occurrence of a suspect flag
must be a warning signal for a manual differential
revision.
Agreement in the result of the "five-part" differential
was established when the Coulter STKS result was
within the Rurnke interval (5) of the manual differ-
ential. For this purpose we first considered the results
for the neutrophils, then the lymphocytes, monocytes,
eosinophils and finally the basophils. Agreement
ought to be present for all 5 cell types. Agreement
was found for 779 (79%) of the 985 patient samples
(except the neonatal samples). The 206 samples which
did not agree were subjected to a 400-cell revision.
After revision there was agreement for 903 patient
samples (92%). The group of patient samples for
which no numerical agreement was found was sub-
divided. Neutrophils and lymphocytes did not give
different results with the two types of differentials. In
the manual differential higher percentages of mono-
cytes and eosinophils were found, whereas the Coulter
STKS gave higher percentages of basophils.
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Agreement normal/abnormal in the patient small differences in percentages, and they showed
populat ion (with the exception of neonatal higher percentages or percentages exceeding the ref-
samples) erence values in the manual differential (especially for
lymphocytes and basophils). For the remaining two
In order to rationalise differential requests, clear and ^ ^
 found L5% myelocytes in the (400 cell)
straightforward indications should be present In any ^^
 differential in Qne sample (= score 2)> while
case, the physician who requests a differential wants
 ±Q ^ ^ ^ ^ did nQt generate a ^ ^ su$pect
to know whether the result of the analysis is normal
 flag ^ ^  ^  OTt gample wg found J9% Wasts
or abnormal. We have tried to subdivide the results .n ^  m ^  differential (in the 400.cell> 8 go/o) The
of the differentials in these two groups. A differential ^^
 SJKS djd ^  g.ye ft ^  flag ($uspect flag
result was regarded as normal if the results were
 no ^ or other t flag This patient ^
within the reference values (see tab. 1), no relevant ^^ ^
 us ^  & myelf)fibrosis
comment was found in the manual differential (total
score 0 or 1), and when the Coulter STKS did not Table 3 shows that a blast flag was found 29 times in
generate suspect flags. The results are described in the 1016 patient population. Blasts were found only
table 4. After revision of discrepancies only 18 false 3 times in the manual differential (PV+ = 10%).
negatives (1.8%) and 84 false positives (8.5%) were There were 3 false negatives (0.3%), one being the
found. The sensitivity and specificity become 96.3% patient with myelofibrosis mentioned earlier, the other
and 83.3% respectively, and the predictive value of a two having a suspect flag (immature granulocytes/
negative result (PV-) on the Coulter STKS becomes bands, tab. 3); in table 4, these latter two were in-
high (95.5%). Patients of all ages were present in the eluded in the column, STKS abnormal. Both these
group of 18 false negatives. In this group, 16 differ- samples had 1% blasts in the 100-cell differential,
entials were judged as being divergent on the basis of while no blasts were found in the 400 cell differential.
Tab. 4. Agreement with respect to normal/abnormal in the patient population (with the exclusion of neonatal samples)
Coulter STKS
Abnormal Normal Total
Microscope differential
Sensitivity
Specificity
Efficiency
PV-
PV +
(100 cell count)
79%
73%
76%
74%
78%
Abnormal
Normal
Total
424
123
547
112
326
438
536
449
985
The result for the differential is normal if:
— the differential quantities are within the reference values (see tab. 1)
— when there is no relevant comment on the manual differential (total score 0 or 1)
— there are no suspect flags on the Coulter STKS
Tab. 5. Agreement with respect to leftshift in the patient population (with the exception of neonatal samples)
Coulter STKS
Manual differential (100 cell count)
Abnormal
Abnormal 52
Normal 87
Total 139
Normal
26
820
846
Total
78
907
985
Sensitivity 67%
Specificity 90%
Efficiency 89%
PV- 97%
PV+ 37% ,;
Leftshift is present when:J~rW>l 1011111 1O iWdtrllL W1JV*11.
- the score assigned to percentages of the precursors of segments and/or the presence of toxic granulation and Dohle is ^  2.
- when there is a suspect flag indicating immature granulocytes/bands (tab. 3, suspect flag no. 2) on the Coulter STKS.
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One sample had a strong leftshift (score 10!), the other
sample only had a raised percentage of segments
(93%).
A good indication for a differential is the suspicion
of a bacterial infection. For that purpose it is worth-
while to look for a leftshift. Table 5 shows the results
of analysis for leftshift (with the exception of neonatal
samples). After revision of discrepancies, only 19 false
negatives were found (1.9%) with a PV- of 97.8%.
The PV + , however, was moderate (40.3%) with a
relatively low number of false positives (8.4%). In the
group of 19 false negatives there was one patient
sample with 11 % bands, 2% metamyelocytes and 1 %
myelocytes and one sample with 13% bands and toxic
granulation. It is striking that 12 times over, there
was a faulty low percentage of myelocytes (< 2%).
The other samples only had marginal differences. We
do not have data for the other deviations (such as
lymphocytosis, abnormal red cells or malignancies) as
the number of patients in these groups was too lim-
ited.
Neonatal samples
During the evaluation period a limited number of
neonatal samples was analysed. Microtainers contain-
ing samples of neonates have to be analysed on the
Coulter STKS with the manual mode. Because of the
number of samples with a suspect flag "Review slide"
(see tab. 3), only 53 neonatal samples were included
in a comparison of the white blood cells. The suspect
flag "blast" (tab. 3, flag no. 1) was found 11 times,
while we could not demonstrate blasts in the corre-
sponding film wedges. We found normoblasts in the
400-cell count, 6 times, whereas the Coulter STKS
gave a normoblast warning (erythroblast, tab. 3, flag
no. 5) 12 times. For this quantity the PV- was 92%
and the PV + was 17%. The number of false negatives
was 6% and the number of false positives 16%.
For the indication leftshift we found 8 positive sam-
ples in the 400-cell manual count and 22 positive
samples on the Coulter STKS. For the indication
leftshift the PV- was 90% and the PV+ was 23%.
The fraction of false negatives was 6% and the frac-
tion of false positives 32%. We could not subdivide
the neonatal samples into normal/abnormal, because
we did not have reference values for this particular
population.
Authorisat ion procedure
The results of the evaluation were used to draft a
flowchart for use in a daily situation. To manage the
amount of requests we coupled the Coulter STKS
Was there a
request for the
quantity?
Do not report
Are there any
suspect or
definitive flags?
Do not approve
nor disapprove
the quantities
concerned,
proceed to the
second
authorisation
Does one of the
results exceed
the service values
or is there a
quantity flag?
Do not approve
nor disapprove
all test results,
proceed to the
second
authorisation
Approve all
remaining
results
Fig. 1. Flowchart automated authorisation Coulter STKS.
with the host computer via a PC. Samples with bar-
code labels were placed in random order in the cas-
settes of the Coulter STKS. Via the PC two types of
authorization procedures based on the results of the
evaluation were executed. In the first (automatic)
procedure, results were compared with fixed criteria.
Results of quantities which were not requested were
not reported. The fixed criteria are based on definitive
and relevant suspect flags and on alert values. Results
of samples which did not fulfil the first procedure
were evaluated with a second authorization proce-
dure. In this manual procedure the results are com-
pared with earlier data, if present. The flowcharts are
shown in figures 1 and 2.
Performance of the Coulter STKS in actual
practice, compared with the evaluat ion
During a period of 2 months we compared the per-
formance of the Coulter STKS with the results of the
evaluation. A total of 4151 patient samples with a
differential request was analysed in this period. We
expected a reduction of the manual differentials of
about 70% for the total population. The number of
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Was there a relevant medical indication? Yes Manual differential
Is one of the following flags present: Blasts,
Immature granulocytes/bands, Variant
lymphocytes, Review slide, Nucleated red blood
cells
Manual differential
Does it concern a sample
than 7 days old?
Df a neonate younger Ve»oxes Manual differential
Does one of the quantities exceed one of the
following limits:
Haemoglobin < 5 or > 12 mmol/1,
Leukocytes < 2.5 or > 20.0 χ 109/1
Erythrocytes > 6.5 χ 1012/1?
Is there an agreement with earlier data?
No
Report STKS differential Manual differential Report STKS differential
Fig. 2. Flowchart manual authorisation Coulter STKS, decision for manual differential
patient samples with the exclusion of neonatal sam-
ples was 3556. From these samples we reported 2738
(77.0%) STKS results and had to perform a manual
differential on 818 (23.0%) samples. For 318 (9.5%)
reviewed samples we did not find relevant discrep-
ancies, so we reported the STKS results. For the
remaining 500 (14.9%) we reported the results of the
manual differential.
The number of analysed neonatal samples was 595.
We reported the STKS results for 141 (23.7%) sam-
ples, and 454 neonatal samples were reviewed. For
122 (20.5%) of the reviewed neonatal samples we did
not find relevant discrepancies, and therefore reported
the STKS results. The remaining 332 samples (55.8%)
were reported according to the manual differentials.
The overall reduction of the manual differentials was
69.4%.
What is the relevance of the suspect flags
For the 3556 samples (the neonatal samples were not
included) we checked whether the flags "Blasts" and
"Variant lymphs" had any significance. The suspect
flag "Blasts" was found in 149 samples (4.2%). Upon
manual review we detected blasts or normoblasts in
only 4 samples. During the evaluation we found this
suspect flag in 2.9% of the samples.
The flag "Variant lymphs" was found in 84 samples
(2.4%), and the manual investigation confirmed 73
of these.
The Coulter STKS and the problem of the
basophils
In a number of cases (about 5%), the Coulter STKS
scattergram showed that the subpopulations were not
properly separated. In these cases, we found a high
percentage of basophils (sometimes even up to 44%).
When the samples were re-analysed after 30 minutes,
normal percentages of basophils were found. This
could be a mixing problem associated with the type
of sampling tubes we use (small diameter). If a ba-
sophil fraction > 4% was found after re-analysis, the
samples were manually reviewed.
Discussion
The results of the evaluation indicate that the analyt-
ical performance of the Coulter STKS is satisfactory.
The stability of the samples for differential purpose
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is 8 hours at room temperature. In an evaluation of
the Coulter VCS a stability of 5 hours was found (1).
A manual differential based on a 100-cell count gives
an analytical variation due to the unequal distribution
of cells on the film wedge as well as a variation which
can be explained on statistical grounds. In a number
of cases the normal physiological variation is greater
than changes caused by disease (7). A request for a
manual differential is only meaningful when there is
a relevant medical indication. The precision of the
differential depends on the total number of counted
cells (5). Automated differentials have an advantage
because they count a larger number of cells (up to
8000).
The STKS results for the neutrophils, lymphocytes
and eosinophils correlated well with the results for
the manual differential. For the monocytes a fair
correlation of 0.550 was obtained. These results are
in agreement with other evaluation reports (1, 8).
Barnard & al. (1) compared the Coulter VCS with the
4 χ 200 cells manual differential (4 technologists
counting 200 cells each). The Coulter VCS has the
option "clinical mode" and "research mode", which
enables the user to correct the unequal distribution
of the monocytes in the film wedge. The Coulter STKS
does not have this option. We found higher percent-
ages of monocytes by manual observation. This is in
contrast to the results of Barnard et al. (1) for the
Coulter VCS, but in agreement with the results of
Warner et al. (9,10). The correlation for the basophils
was poor. This can be attributed to the low percentage
of basophils in the film wedge and also to an inciden-
tal higher count of the STKS probably caused by
mixing problems.
The numerical agreement of 92% between the STKS
and manual differential is good. For that reason the
STKS gives good results even for abnormal differen-
tials.
After revision of the discrepancies as shown in the
table normal/abnormal {tab. 4) we found 8.5% false
negatives and 1.8% false positives. These results are
within the recommendations of Krause (11) and are
comparable with evaluation reports of the Coulter
VCS (1), Coulter STKS (10) and Sysmex 5000 (12).
Barnard et al. found 12.2% false negatives in their
VCS evaluation, but they commented that this would
have been reduced to 0.9% for a comparison with the
100 cell count. They defined the presence of a devi-
ating cell as abnormal, without considering the num-
ber of counted cells. In our study a sample is consid-
ered abnormal on the basis of percentages.
The results of our study show that the Coulter STKS
can be used for prescreening purposes. Only one false
negative sample was missed. To avoid real false neg-
atives we have adapted our procedure, and with the
proposal made in the flowcharts we are convinced
that there is an extremely low chance of missing
abnormal patients.
The STKS is reasonably capable of signalling the
presence of a leftshift, but the number of false posi-
tives is relatively high. By using the authorization
procedure in a daily situation we have reduced the
number of unnecessary reviews.
We had a high number of neonatal samples with
suspect flags during the evaluation (75%). This is not
remarkable, since the software of the STKS Data
Management System has been developed for and
based on an adult population. The predictive value
of a positive test is low, as far as normoblasts and
the indication leftshift are concerned, so the number
of false positives is high. In a daily situation it means
that a large number of neonatal samples has to be
reviewed. This was confirmed in the follow-up period.
In our opinion the Coulter STKS is an acceptable
haematology analyser which can reduce the daily
manual differential work-load by up to 70%. By
managing the huge amount of data generated by the
Coulter STKS via the flowcharts, and by coupling the
STKS with the laboratory host computer, the possi-
bility of false negative results is greatly reduced. We
are well aware that a haematology analyser with a
full white blood cell differential count can never fully
replace the manual differential, and that it will there-
fore be necessary to maintain relevant and specialised
expertise in cell morphology.
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